Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Summary:
Analysis of E2F-1 overexpressing SK-MEL-2 melanoma cells treated with the anti-cancer drug doxorubicin (dox). Results provide insight into the molecular mechanisms underlying the synergistic effect on melanoma cell apoptosis observed when E2F-1 overexpression is combined with dox treatment
GPL96:
[HG-U133A] Affymetrix Human Genome U133A Array
Citation:
Hao H, Dong YB, Bowling MT, Zhou HS et al. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin. Anticancer Res 2006 May-Jun;26(3A):1947-56. PMID: 16827129
